More articles from Article

You have access
Interaction of Human OATP1B1 with PDZK1 Is Required for Its Trafficking to the Hepatocyte Plasma Membrane
Pijun Wang, John W. Murray and Allan W. Wolkoff

Drug Metabolism and Disposition October 2023, 51 (10) 1342-1349; DOI: https://doi.org/10.1124/dmd.123.001248
You have access
Impact of Heterotropic Allosteric Modulation on the Time-Dependent Inhibition of Cytochrome P450 3A4
Luc R.A. Rougée, David W. Bedwell, Kasi Hansen, Trent L. Abraham and Stephen D. Hall

Drug Metabolism and Disposition October 2023, 51 (10) 1372-1380; DOI: https://doi.org/10.1124/dmd.123.001382
You have access
Prediction of Human Pharmacokinetics of Phosphorodiamidate Morpholino Oligonucleotides in Duchenne Muscular Dystrophy Patients Using Viltolarsen
Shunji Imai, Yusuke Suda, Jumpei Mori, Yoshihiro Sasaki, Tetsuhiro Yamada and Kazutomi Kusano

Drug Metabolism and Disposition October 2023, 51 (10) 1428-1435; DOI: https://doi.org/10.1124/dmd.123.001425
You have access
Analysis of the Bile Acid Composition in a Fibroblast Growth Factor 19-Expressing Liver-Humanized Mouse Model and Its Use for CYP3A4-Mediated Drug–Drug Interaction Studies
Mario Mezler, Robert S. Jones, Dewakar Sangaraju, Devorah C. Goldman, Matthew Hoffmann, Aki T. Heikkinen, Janne Mannila, Jae H. Chang, Lander Foquet, Sandeepraj Pusalkar, Paresh P. Chothe and Nico Scheer

Drug Metabolism and Disposition October 2023, 51 (10) 1391-1402; DOI: https://doi.org/10.1124/dmd.123.001398
You have access
The Potentially Significant Role of CYP3A-Mediated Oxidative Metabolism of Dabigatran Etexilate and Its Intermediate Metabolites in Drug-Drug Interaction Assessments Using Microdose Dabigatran Etexilate
Udomsak Udomnilobol, Suree Jianmongkol and Thomayant Prueksaritanont

Drug Metabolism and Disposition September 2023, 51 (9) 1216-1226; DOI: https://doi.org/10.1124/dmd.123.001353
You have access
The Influence of Lipid Microdomain Heterogeneity on Protein-Protein Interactions: Proteomic Analysis of Co-Immunoprecipitated Binding Partners of P450 1A2 and P450 3A in Rat Liver Microsomes
James R. Reed, Jessie J. Guidry, Marilyn Eyer and Wayne L. Backes

Drug Metabolism and Disposition September 2023, 51 (9) 1196-1206; DOI: https://doi.org/10.1124/dmd.123.001287
Open Access
Improvement of Protein Expression Profile in Three-Dimensional Renal Proximal Tubular Epithelial Cell Spheroids Selected Based on OAT1 Gene Expression: A Potential In Vitro Tool for Evaluating Human Renal Proximal Tubular Toxicity and Drug Disposition
Naoki Ishiguro, Etsushi Takahashi, Hiroshi Arakawa, Asami Saito, Fumihiko Kitagawa, Masayuki Kondo, Gaku Morinaga, Masahito Takatani, Ryo Takahashi, Takashi Kudo, Shin-ichi Mae, Moeno Kadoguchi, Daichi Higuchi, Yuya Nakazono, Ikumi Tamai, Kenji Osafune and Yoichi Jimbo

Drug Metabolism and Disposition September 2023, 51 (9) 1177-1187; DOI: https://doi.org/10.1124/dmd.122.001171
You have access
In Vitro Evaluation of the Reductase Activities of Human AKR1C3 Allelic Variants
Shiori Takano, Tatsuki Fukami, Hiroyuki Ichida, Kohei Suzuki, Masataka Nakano and Miki Nakajima

Drug Metabolism and Disposition September 2023, 51 (9) 1188-1195; DOI: https://doi.org/10.1124/dmd.123.001264
You have access
Adipocyte-Derived PXR Signaling Is Dispensable for Diet-Induced Obesity and Metabolic Disorders in Mice
Fang Wang, Jingwei Liu, Rebecca Hernandez, Se-Hyung Park, Ying-Jing Lai, Shuxia Wang, Bruce Blumberg and Changcheng Zhou

Drug Metabolism and Disposition September 2023, 51 (9) 1207-1215; DOI: https://doi.org/10.1124/dmd.123.001311
You have access
Sex- and Lifestyle-Related Factors are Associated with Altered Hepatic CYP Protein Levels in People Diagnosed with Mental Disorders
Kata W. Pedersen, Jakob Hansen, Jytte Banner, Jørgen B. Hasselstrøm and Jakob R. Jornil

Drug Metabolism and Disposition September 2023, 51 (9) 1169-1176; DOI: https://doi.org/10.1124/dmd.122.001125

Main menu

User menu

Search

More articles from Article

Pages

Navigate

More Information

ASPET's Other Journals